Research area
Phase 3 Melanoma trials
The melanoma studies listed here are all in Phase 3, including combined Phase 2/3. If you are wondering whether one may be a fit, Phase 3 Cancer Trials can help you find out.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Phase 3 melanoma studies in numbers
- Phase 3 melanoma studies recruiting in the U.S.
- 17
- states with a study site
- 48
Source: ClinicalTrials.gov. Data processed .
Find Phase 3 melanoma studies by state
These states have the most studies recruiting right now.
Florida
13 studies recruiting.
Pennsylvania
13 studies recruiting.
Arizona
12 studies recruiting.
New York
12 studies recruiting.
Ohio
12 studies recruiting.
California
11 studies recruiting.
Phase 3 melanoma studies recruiting now
As of November 18, 2026, 17 Phase 3 melanoma studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 3, including combined Phase 2/3, as each study is coded in the registry. This is what they have in common.
What they test
- medications13
- biologics such as vaccines or antibodies5
- procedures4
- diagnostic tests2
- other approaches2
A study can test more than one.
Main purpose
- treating a condition15
- diagnosis2
Phase
- Phase 2/33
- Phase 314
Who runs them
- industry13
- university, hospital or other4
Who they enroll
- adults (18 to 64)16
- older adults (65 and over)17
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 17 studies.
Recently updated Phase 3 melanoma studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Phase 3
- Ages 75 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Albuquerque, NM · Anaconda, MT · Arroyo Grande, CA · and 140 more U.S. locations
- Registry record
- NCT07068074 · updated
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Recruiting in
- Cleveland, OH · Nashville, TN · Philadelphia, PA · and 2 more U.S. locations
- Registry record
- NCT07804186 · updated
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Recruiting in
- Albany, NY · Ann Arbor, MI · Asheville, NC · and 71 more U.S. locations
- Registry record
- NCT06246916 · updated
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Immatics US, Inc.
- Recruiting in
- Allentown, PA · Ann Arbor, MI · Atlanta, GA · and 35 more U.S. locations
- Registry record
- NCT06743126 · updated
Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- Basking Ridge, NJ · Commack, NY · Harrison, NY · and 4 more U.S. locations
- Registry record
- NCT07890415 · updated
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Eikon Therapeutics
- Recruiting in
- Bethesda, MD · Canton, OH · Chandler, AZ · and 11 more U.S. locations
- Registry record
- NCT06697301 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in the United States on ClinicalTrials.gov.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that are in Phase 3, including combined Phase 2/3, as each study is coded in the registry.
Phase 3 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
What Phase 3 melanoma studies look at
The melanoma studies you find here are all in Phase 3, including combined Phase 2/3. Each trial sets out to settle a single question of its own. So your part in one melanoma trial can look quite different from your part in another.
Every product under test in these trials is investigational. How well it works remains an open question, and so do its risks. Finding those answers is the reason the trial is run.
Who may be able to take part
Who can take part depends on the study, because each one sets its own requirements. These can cover your age, your health history, the medications you take now, and how melanoma affects you. Some studies also enroll people who do not have it.
Working out eligibility is not something you have to do alone. The study team checks it at a screening visit. Learn how eligibility and screening work.
What taking part usually involves
A first conversation
Nothing happens until you have spoken with a coordinator. You hear a broad outline of the melanoma trial, and they answer what you ask.
Informed consent
Before you decide anything, the people running the Phase 3 trial put the full details on paper for you. Known risks are part of that written information. Whether you agree is your call.
Screening
To check whether this Phase 3 trial is a fit, you answer questions about your health and have some tests. Some people who go through screening do not go on to join.
Study visits
Should you join, the team keeps track of your health at visits set on a schedule. You are free to stop taking part whenever you choose.
Questions about Phase 3 melanoma studies
Do I need a diagnosis to join a study about melanoma?
There is no single answer across melanoma trials. In some, you need a diagnosis that is already confirmed. In others, the assessment happens at screening. The team running each trial will explain which is the case for theirs.
Would I have to change the care I receive now?
Please do not change any of your care on your own. Some studies let current care continue, and some do not. The study doctor goes over this with you. Before you decide, you can also discuss it with your own doctor.
Is there a cost to take part?
Generally, you are not charged as a participant. Visits and tests that are part of the Phase 3 study come at no cost to you, and so does the study medication. Our costs page explains more.
Ask about Phase 3 melanoma studies
A coordinator will contact you once you give us some basic details. Asking about a Phase 3 melanoma trial leaves you free of any commitment.
Independent information
- Skin Cancer (Including Melanoma) — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)